MILWAUKEE, Nov. 22, 2022 /PRNewswire/ -- Ademi LLP is investigating Graybug (Nasdaq: GRAY) for possible breaches of fiduciary duty and other violations of law in its transaction with CalciMedica.
Click here to learn how to join the action https://www.ademilaw.com/case/graybug-vision-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges Graybug's financial outlook and prospects are excellent and yet Graybug equity holders are expected to collectively own only approximately 29% of the combined company, and pre-merger CalciMedica equity holders are expected to collectively own approximately 71% of the combined company, in each case, on a fully diluted basis using the treasury stock method. The percentage of the combined company that Graybug's equity holders will own as of the close of the transaction is subject to certain adjustments as described in the merger agreement, including an adjustment based on the amount of Graybug's net cash at closing. The transaction agreement unreasonably limits competing bids for Graybug by imposing a significant penalty if Graybug accepts a superior bid. Graybug insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Graybug's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Graybug.
If you own Graybug common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/graybug-vision-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-graybug-vision-inc-has-entered-into-a-fair-transaction-with-calcimedica-301685185.html
SOURCE Ademi LLP
